A Malaria Vaccine

Mosquito Larvae

Mosquito Larvae Suspended in a Water Droplet
Photo: Dr. John H. Brackenbury

After many years of effort, a malaria vaccine appears closer to reality. GSK submitted a regulatory filing for a vaccine. Approval would be a step toward making the vaccine available. The vaccine is not 100% effective so it is proposed to be used in conjunction with other measures. It may be able to reduce malaria infection in young children by almost half. The development costs so far have exceeded a half billion dollars, and the final cost may well be over a 1 $Billion. GSK has been investigating a malaria vaccine for over 30 years. The cost may be high but the costs imposed by malaria on humans is even higher.

About jjneal

Jonathan Neal is a retired Associate Professor of Entomology at Purdue University and author of the textbook, Living With Insects (2010). This blog is a forum to communicate about the intersection of insects with people and policy. This is a personal blog. The opinions and materials posted here are those of the author and are in no way connected with those of my employer.
This entry was posted in by jjneal, Health, News. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s